Complementary adenoviral vector systems and cell lines
US7195896B2 · kind B2 · utility
28Cited by
14References
40Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 26, 2001 |
| Grant date | Mar 27, 2007 |
| Priority date | — |
| Expiry date | Dec 29, 2023 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S977/799
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides multiply deficient adenoviral vectors and complementing cell lines. Also provided are recombinants of the multiply deficient adenoviral vectors and a therapeutic method, particularly relating to gene therapy, vaccination, and the like, involving the use of such recombinants.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.